Century Therapeutics (NASDAQ:IPSC) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Century Therapeutics (IPSC) operate in?

Century Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Century Therapeutics Stock (NASDAQ: IPSC) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 614.24K
Day Range	- - -
52 Wk Range	0.68 - 5.51
Market Cap	$62.50M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	30
Short Interest	4.42%
Days to Cover	5.58

Recent News

Century Therapeutics Stages Highest Single Day Move In 11 Months As Casdin Capital Bumps Its Stake To 5.4%

Rishabh Mishra

Robinhood To Rally Around 29%? Here Are 10 Top Analyst Forecasts For Thursday

Avi Kapoor

Small-Cap Firm Century Therapeutics' Expands into Autoimmune Diseases, Analyst Says Clade Therapeutics Acquisition Intriguing

Century Therapeutics unveils plans to expand CNTY-101 clinical development into additional autoimmune diseases, including systemic lupus erythematosus. $60 million private placement supports R&D activities. Acquisition of Clade Therapeutics enhances pipeline with iPSC-focused programs.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov 24

Dec 24

Jan

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	0 / 614.24K
Day Range	- - -
52 Wk Range	0.68 - 5.51
Market Cap	$62.50M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	30
Short Interest	4.42%
Days to Cover	5.58

About Century Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Century Therapeutics Inc is a biotechnology company specializes in leveraging adult stem cells to de...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Century Therapeutics (IPSC) stock?

You can purchase shares of Century Therapeutics (NASDAQ:IPSC) through any online brokerage.

View our list of the best stock brokerages

Who are Century Therapeutics (IPSC) competitors?

Other companies in Century Therapeutics’s space includes: CytomX Therapeutics (NASDAQ:CTMX), Estrella Immunopharma (NASDAQ:ESLA), bluebird bio (NASDAQ:BLUE), Gain Therapeutics (NASDAQ:GANX) and vTv Therapeutics (NASDAQ:VTVT).

What is the forecast, or price target, for Century Therapeutics (IPSC) stock?

Century Therapeutics has a consensus price target of $11.75.

What is the current price for Century Therapeutics (IPSC)?

The stock price for Century Therapeutics (NASDAQ: IPSC) is $0.7351 last updated February 20, 2025 at 4:33 PM EST.

Does Century Therapeutics (IPSC) pay a dividend?

There are no upcoming dividends for Century Therapeutics.

When is Century Therapeutics (NASDAQ:IPSC) reporting earnings?

Century Therapeutics’s Q1 earnings are confirmed for Thursday, May 8, 2025.

Is Century Therapeutics (IPSC) going to split?

There is no upcoming split for Century Therapeutics.

What sector and industry does Century Therapeutics (IPSC) operate in?

Century Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Century Therapeutics

Century Therapeutics (IPSC) Forecast